R&D News | pharmaphorum

News

Roche expands phase 3 plans for Alzheimer's drug

Roche has added a phase 3 trial of trontinemab, hoping to show it can delay or prevent progression to Alzheimer's symptoms in preclinical patients.

News

GSK forges $12bn alliance with China's Hengrui

GSK has moved to shore up its R&D pipeline with a strategic-level partnering deal with China's Jiangsu Hengrui Pharma.

News

AZ boasts phase 3 win for self-administered gMG drug

Alexion has announced high-level positive results from a phase 3 trial of gefurulimab, a once-weekly self-administered treatment for gMG.

News

mRNA ‘wake-up call’ shows promise as universal cancer vaccin...

Researchers at the University of Florida have developed a new mRNA-based vaccine that, when combined with checkpoint inhibitor immunotherapy, significantly boosted anti-tumour activit

News

Scancell points to 'strong' melanoma vaccine data

Scancell has the results it was hoping for with its melanoma immunotherapy iSCIB1+ and is accelerating plans for a pivotal trial.

News

AstraZeneca reveals $50bn investment in US facilities

Trump's pharma tariffs haven't appeared yet, but AstraZeneca has joined several of its peers with big investments in US manufacturing and R&D.

Roche expands phase 3 plans for Alzheimer's drug

GSK forges $12bn alliance with China's Hengrui

AZ boasts phase 3 win for self-administered gMG drug

mRNA ‘wake-up call’ shows promise as universal cancer vaccin...

Scancell points to 'strong' melanoma vaccine data

AstraZeneca reveals $50bn investment in US facilities

UK budget includes £1bn biopharma investment package

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks